不同流量经鼻高流量氧疗预给氧在择期手术患者中的随机对照试验
这项前瞻性随机单盲试验纳入72例ASA 1-3级择期手术患者,比较45、70、95 L min-1三种经鼻高流量氧疗流量预给氧的效果。主要结局安全呼吸暂停时间在三组间无差异,45 L min-1组不适感最低,且预给氧效果与高流量相当。
要点
- 45、70、95 L min-1三种流量预给氧的安全呼吸暂停时间无差异。
- 45 L min-1组预给氧相关不适感低于70和95 L min-1组。
- 将预给氧流量从45提高至70 L min-1可能不会延长安全呼吸暂停时间。
核心结论
- 三种经鼻高流量氧疗流量预给氧的安全呼吸暂停时间无差异。
- 45 L min-1产生的不适感最低,且预给氧效果与更高流量相当。
- 将预给氧流量从45提高至70 L min-1可能不会延长安全呼吸暂停时间。
研究设计与样本
- 前瞻性、随机、单盲临床试验,纳入72例18-84岁ASA 1-3级择期手术患者。
- 预给氧采用经鼻高流量氧疗,随机分为45、70、95 L min-1三组,三组平均预给氧时长均为250 s。
- 主要结局为呼吸暂停至SpO2达93%的时间;次要结局为预给氧期间PaO2和预给氧相关不适感。
主要发现
- 呼吸暂停时间无差异,45、70、95 L min-1组中位时间分别为472、523、483 s(P=0.59)。
- 呼吸暂停开始时,95 L min-1组PaO2高于45 L min-1组。
- 预给氧期间其他PaO2比较未观察到差异。
- 45 L min-1组不适感水平低于70和95 L min-1组。
临床怎么用
- 择期手术患者预给氧可考虑使用45 L min-1经鼻高流量氧疗,以降低不适感且不缩短安全呼吸暂停时间。
- 无需为提高安全呼吸暂停时间而将预给氧流量从45 L min-1提升至70 L min-1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-flow nasal oxygen (HFNO) is increasingly used for preoxygenation. Previous studies of preoxygenation have explored flow rates below 60 L min-1. This study aimed to compare different HFNO flow rates during preoxygenation to identify the most effective flow rate for clinical use. METHODS: This randomised trial included patients aged 18-84 yr of ASA physical status 1-3 scheduled for elective surgery. Preoxygenation was conducted using HFNO at randomised flow rates of 45, 70, or 95 L min-1. After preoxygenation, patients rated their level of preoxygenation-related discomfort. HFNO was discontinued at apnoea start. After intubation, apnoea was maintained until Spo2 reached 93%. Primary outcome was apnoea time until Spo2=93%. Secondary outcomes were Pao2 levels during preoxygenation and preoxygenation-related discomfort. RESULTS: Of 72 participants included in the final analysis, baseline characteristics were similar and the mean duration of preoxygenation was 250 s in all three groups. Apnoea times did not differ, with median durations of 472, 523, and 483 s for 45, 70, and 95 L min-1, respectively (P=0.59). At apnoea onset, 95 L min-1 produced higher Pao2 than 45 L min-1. No other differences in Pao2 were observed during preoxygenation. The level of discomfort was lower for 45 L min-1 compared with 70 and 95 L min-1. CONCLUSIONS: There was no difference in the safe apnoea time between preoxygenation with the three flow rates. As 45 L min-1 generated the least discomfort while providing preoxygenation effectiveness comparable with higher flow rates, increasing preoxygenation flow rate from 45 to 70 L min-1 will likely not prolong safe apnoea time. CLINICAL TRIAL REGISTRATION: NCT06736132.
引用
- Sjöblom A, Hoffman F, Hedberg M, et al. Preoxygenation with high-flow nasal oxygen at various flow rates in elective surgical patients: a prospective, randomised, single-blind clinical trial. Br J Anaesth. 2025. PMID: 41419379. doi:10.1016/j.bja.2025.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。